Rezolute says FDA recommends pre-BLA meeting for ersodetug in congenital hyperinsulinism
Bitget2026/10/05 11:09Rezolute received an FDA recommendation to hold a Type B pre-BLA meeting ahead of a potential filing for ersodetug in congenital hyperinsulinism. The Phase 3 sunRIZE study showed glycemic improvement, but missed its primary endpoint, limiting the strength of the main efficacy claim. FDA reviewed extensive continuous glucose monitoring analyses, then urged a pre-BLA discussion without taking a position on approvability. Topline Phase 3 upLIFT results in tumor-related hyperinsulinism are expected this quarter, shaping the broader BLA submission strategy. An open-label extension remains ongoing, supporting longer-term treatment experience and potential durability of benefit. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rezolute Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050700PRIMZONEFULLFEED9839272) on October 05, 2026, and is solely responsible for the information contained therein.
- Rezolute received an FDA recommendation to hold a Type B pre-BLA meeting ahead of a potential filing for ersodetug in congenital hyperinsulinism.
- The Phase 3 sunRIZE study showed glycemic improvement, but missed its primary endpoint, limiting the strength of the main efficacy claim.
- FDA reviewed extensive continuous glucose monitoring analyses, then urged a pre-BLA discussion without taking a position on approvability.
- Topline Phase 3 upLIFT results in tumor-related hyperinsulinism are expected this quarter, shaping the broader BLA submission strategy.
- An open-label extension remains ongoing, supporting longer-term treatment experience and potential durability of benefit.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Europe Becomes a Safe Haven Amid AI Turbulence! Citi Turns Bullish on European Stocks, Downgrades US Stocks: Low AI Exposure Seen as Key Advantage
Citigroup strategists have downgraded the rating of U.S. stocks and upgraded the rating of European stocks, following the recent market turbulence caused by upheaval in the artificial intelligence industry.
Crypto prices
More
